For: | Kim CJ, Cho YG, Park YG, Nam SW, Kim SY, Lee SH, Yoo NJ, Lee JY, Park WS. Pin1 overexpression in colorectal cancer and its correlation with aberrant β-catenin expression. World J Gastroenterol 2005; 11(32): 5006-5009 [PMID: 16124054 DOI: 10.3748/wjg.v11.i32.5006] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i32/5006.htm |
Number | Citing Articles |
1 |
Kazuhiro Nakamura, Isao Kosugi, Daniel Y. Lee, Angela Hafner, David A. Sinclair, Akihide Ryo, Kun Ping Lu. Prolyl Isomerase Pin1 Regulates Neuronal Differentiation via β-Catenin. Molecular and Cellular Biology 2012; 32(15): 2966 doi: 10.1128/MCB.05688-11
|
2 |
Xingxue Yan, Zhendong Zhu, Shenmin Xu, Li-nan Yang, Xin-Hua Liao, Min Zheng, Dayun Yang, Jichuang Wang, Dongmei Chen, Long Wang, Xiaolong Liu, Jingfeng Liu, Ruey-Hwa Chen, Xiao Zhen Zhou, Kun Ping Lu, Hekun Liu. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Scientific Reports 2017; 7(1) doi: 10.1038/srep45915
|
3 |
Jianwen Sun, Lijun Fan, Meining Li, Yuehong Zhang, Niuliang Cheng. Decreasing Pin1 suppresses telomerase activity by NF-κB in HCT116 cells colorectal carcinoma. The Chinese-German Journal of Clinical Oncology 2013; 12(4): 181 doi: 10.1007/s10330-013-1137-7
|
4 |
Lei Xi, Yu Wang, Qing He, Qingyan Zhang, Linfang Du. Interaction between Pin1 and its natural product inhibitor epigallocatechin-3-gallate by spectroscopy and molecular dynamics simulations. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2016; 169: 134 doi: 10.1016/j.saa.2016.06.036
|
5 |
Sanghamitra Mylavarapu, Harsh Kumar, Smita Kumari, L. S. Sravanthi, Misti Jain, Aninda Basu, Manjusha Biswas, Sivaram V. S. Mylavarapu, Asmita Das, Monideepa Roy. Activation of Epithelial-Mesenchymal Transition and Altered β-Catenin Signaling in a Novel Indian Colorectal Carcinoma Cell Line. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00054
|
6 |
Alessandra Monti, Raffaele Ronca, Giuseppe Campiani, Menotti Ruvo, Nunzianna Doti. Expression, Purification, Structural and Functional Characterization of Recombinant Human Parvulin 17. Molecular Biotechnology 2023; 65(3): 337 doi: 10.1007/s12033-022-00493-1
|
7 |
Jonathan Guito, David Lukac. KSHV Reactivation and Novel Implications of Protein Isomerization on Lytic Switch Control. Viruses 2015; 7(1): 72 doi: 10.3390/v7010072
|
8 |
Deepti Gurung, Jacob A Danielson, Afsara Tasnim, Jian-Ting Zhang, Yue Zou, Jing-Yuan Liu. Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities. Biology 2023; 12(7): 1008 doi: 10.3390/biology12071008
|
9 |
Bilal Ahmad Mir, Saiema Rasool, Muneeb U. Rehman, Insha Amin, Rayeesa Ali. Plant and Human Health, Volume 2. 2019; : 139 doi: 10.1007/978-3-030-03344-6_5
|
10 |
Hongfeng Yan, Fuquan Jiang, Jianwu Yang, Ying-Kun Xu. Association of β-Catenin, APC, SMAD3/4, Tp53, and Cyclin D1 Genes in Colorectal Cancer: A Systematic Review and Meta-Analysis. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/5338956
|
11 |
Darya V. Urusova, Jung-Hyun Shim, Dong Joon Kim, Sung Keun Jung, Tatyana A. Zykova, Andria Carper, Ann M. Bode, Zigang Dong. Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1. Cancer Prevention Research 2011; 4(9): 1366 doi: 10.1158/1940-6207.CAPR-11-0301
|
12 |
Shizhen Zhang, Zhen Wang, Jinlan Shan, Xiuyan Yu, Ling Li, Rui Lei, Daozhe Lin, Siqi Guan, Xiaochen Wang. Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma. Medicine 2016; 95(49): e5546 doi: 10.1097/MD.0000000000005546
|
13 |
LU ZHOU, BYUNG-HYUN PARK, JONG HYUK PARK, KYU YUN JANG, HO SUNG PARK, SAJEEV WAGLE, KWANG-BOK LEE, JUNG RYUL KIM. Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells. Oncology Reports 2013; 29(1): 193 doi: 10.3892/or.2012.2112
|
14 |
H Jung, B-G Kim, W H Han, J H Lee, J-Y Cho, W S Park, M M Maurice, J-K Han, M J Lee, D Finley, E-h Jho. Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling. Oncogenesis 2013; 2(8): e64 doi: 10.1038/oncsis.2013.28
|
15 |
Yang Li, Zhongnan Yuan, Linlin Wang, Jing Yang, Pei Pu, Yunting Le, XianWei Chen, Chongyang Wang, Yating Gao, Yi Liu, Jialin Wang, Xu Gao, Yanze Li, Hefei Wang, Chaoxia Zou. Prolyl isomerase Pin1 sculpts the immune microenvironment of colorectal cancer. Cellular Signalling 2024; 115: 111041 doi: 10.1016/j.cellsig.2024.111041
|
16 |
Isao Matsuura, Keng-Nan Chiang, Chen-Yu Lai, Dongming He, Guannan Wang, Romila Ramkumar, Takafumi Uchida, Akihide Ryo, Kunping Lu, Fang Liu. Pin1 Promotes Transforming Growth Factor-β-induced Migration and Invasion. Journal of Biological Chemistry 2010; 285(3): 1754 doi: 10.1074/jbc.M109.063826
|
17 |
Daniel Cury Ogata, Fernando Hintz Greca, Murilo de Almeida Luz, Sérgio Ossamu Ioshii, Flávio Daniel Saavedra Tomasich. Foco de criptas aberrantes e câncer da junção colorretal: análise da presença de lesões precoces microscópicas na periferia do câncer colorretal e correlação com a expressão da β-catenina e Ki-67. Revista do Colégio Brasileiro de Cirurgiões 2010; 37(2): 114 doi: 10.1590/S0100-69912010000200008
|
18 |
Lifei Du, Xiaoyu Wang, Guonan Cui, Bailing Xu. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors. Bioorganic & Medicinal Chemistry 2021; 29: 115878 doi: 10.1016/j.bmc.2020.115878
|
19 |
Yan Zhang, Sebastian Daum, Dirk Wildemann, Xiao Zhen Zhou, Mark A. Verdecia, Marianne E. Bowman, Christian Lücke, Tony Hunter, Kun-Ping Lu, Gunter Fischer, Joseph P. Noel. Structural Basis for High-Affinity Peptide Inhibition of Human Pin1. ACS Chemical Biology 2007; 2(5): 320 doi: 10.1021/cb7000044
|
20 |
Furqan Sami, Caroline Smet-Nocca, Meera Khan, Isabelle Landrieu, Guy Lippens, David L. Brautigan. Molecular Basis for an Ancient Partnership between Prolyl Isomerase Pin1 and Phosphatase Inhibitor-2. Biochemistry 2011; 50(30): 6567 doi: 10.1021/bi200553e
|
21 |
Elizabeth S. Yeh, Anthony R. Means. PIN1, the cell cycle and cancer. Nature Reviews Cancer 2007; 7(5): 381 doi: 10.1038/nrc2107
|
22 |
María Jazmín Abraham Juárez, Rocío Hernández Cárdenas, José Natzul Santoyo Villa, Devin O’Connor, Aaron Sluis, Sarah Hake, José Ordaz-Ortiz, Leon Terry, June Simpson. Functionally different PIN proteins control auxin flux during bulbil development in Agave tequilana. Journal of Experimental Botany 2015; 66(13): 3893 doi: 10.1093/jxb/erv191
|
23 |
Saeideh Gholamzadeh Khoei, Massoud Saidijam, Razieh Amini, Akram Jalali, Rezvan Najafi. Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer. Journal of Gastrointestinal Cancer 2022; 53(2): 299 doi: 10.1007/s12029-021-00600-6
|
24 |
Hyeong-jun Han, Nayoung Kwon, Min-A Choi, Kyung Oh Jung, Juan-Yu Piao, Hoang Kieu Chi Ngo, Su-Jung Kim, Do-Hee Kim, June-Key Chung, Young-Nam Cha, Hyewon Youn, Bu Young Choi, Sang-Hyun Min, Young-Joon Surh, Jörn Karhausen. Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α. PLOS ONE 2016; 11(1): e0147038 doi: 10.1371/journal.pone.0147038
|
25 |
Bainan Wu, Michele F. Rega, Jun Wei, Hongbin Yuan, Russell Dahl, Ziming Zhang, Maurizio Pellecchia. Discovery and Binding Studies on a Series of Novel Pin1 Ligands. Chemical Biology & Drug Design 2009; 73(4): 369 doi: 10.1111/j.1747-0285.2009.00795.x
|
26 |
Jung Il Chae, Jung Hyun Shim, Kwang Su Lee, Young Sik Cho, Kyu-Sun Lee, Do Young Yoon, Soo Hyun Kim, Hyung-Min Chung, Deog-Bon Koo, Chang-Sik Park, Dong-Seok Lee, Pyung Keun Myung. Downregulation of immune response by the human cytokines Interleukin-32α and β in cell-mediated rejection. Cellular Immunology 2010; 264(1): 47 doi: 10.1016/j.cellimm.2010.04.010
|
27 |
Meng Xu, Chartia Ching-Mei Cheung, Chit Chow, Samantha Wei-Man Lun, Siu-Tim Cheung, Kwok-Wai Lo, Pierre Busson. Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma. PLOS ONE 2016; 11(6): e0156833 doi: 10.1371/journal.pone.0156833
|
28 |
Junghoon Kim, Seonock Lee, Ruijing Sun, Jungho Kim. Juglone and KPT6566 Suppress the Tumorigenic Potential of CD44+CD133+ Tumor-Initiating Caco-2 Cells In Vitro and In Vivo. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.861045
|
29 |
S. G. Khoei, C. Mohammadi, Y. Mohammadi, S. Sameri, R. Najafi. Prognostic value of peptidyl-prolyl cis–trans isomerase 1 (PIN1) in human malignant tumors. Clinical and Translational Oncology 2020; 22(7): 1067 doi: 10.1007/s12094-019-02233-5
|
30 |
Guo-Liang Huang, Jin-Hua Qiu, Bin-Bin Li, Jing-Jing Wu, Yan Lu, Xing-Yan Liu, Zhiwei He. Prolyl Isomerase Pin1 Regulated Signaling Pathway Revealed by Pin1 +/+ and Pin1 −/− Mouse Embryonic Fibroblast Cells. Pathology & Oncology Research 2013; 19(4): 667 doi: 10.1007/s12253-013-9629-x
|
31 |
Tao Wang, Zi Liu, Fan Shi, Jiquan Wang. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer. Molecular and Cellular Biochemistry 2016; 413(1-2): 179 doi: 10.1007/s11010-015-2651-4
|
32 |
D Kim, O Rath, W Kolch, K-H Cho. A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways. Oncogene 2007; 26(31): 4571 doi: 10.1038/sj.onc.1210230
|
33 |
Shue Li, Mao Huang, Qiao Liu, Ding Wang, Rui Wu, Xiuyu Zhang, Weixian Chen, Liang Duan. Serum Expression of β-Catenin Is a Potential Detection Marker in Patients with Colorectal Cancer. Disease Markers 2019; 2019: 1 doi: 10.1155/2019/5070524
|
34 |
Guoliang Fan, Lin Wang, Jia Xu, Ping Jiang, Wei Wang, Ying Huang, Minggang Lv, Shaoting Liu. Knockdown of the prolyl isomerase Pin1 inhibits Hep-2 cell growth, migration, and invasion by targeting the β-catenin signaling pathway. Biochemistry and Cell Biology 2018; 96(6): 734 doi: 10.1139/bcb-2017-0334
|
35 |
Jung-Soo Pyo, Byoung Kwan Son, Il Hwan Oh. Cytoplasmic Pin1 expression is correlated with poor prognosis in colorectal cancer. Pathology - Research and Practice 2018; 214(11): 1848 doi: 10.1016/j.prp.2018.09.018
|